CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-01 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise | +16,350 | 30,350 | ||
| 2021-11-01 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise · Restricted Stock Units | −16,350 | 81,750 | ||
| 2021-07-01 | LANCHONEY DIANA M Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-07-01 | LANCHONEY DIANA M Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-07-01 | LANCHONEY DIANA M Director | Grant or award · Restricted Stock Unit | +69,400 | 69,400 | ||
| 2021-07-01 | Hollingsworth Jane H Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-07-01 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-07-01 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-07-01 | Francois Eric Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-07-01 | Francois Eric Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-07-01 | Francois Eric Director | Grant or award · Restricted Stock Unit | +69,400 | 69,400 | ||
| 2021-07-01 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2021-05-13 | Hollingsworth Jane H Director | Purchase | +32,786 | $0.61 | $20K | 32,786 |
| 2021-03-01 | Cobuzzi Robert Joseph Jr. President & CEO | Grant or award · Stock Option (Right to Buy) | +53,713 | 53,713 | ||
| 2021-03-01 | Cobuzzi Robert Joseph Jr. President & CEO | Grant or award · Stock Option (Right to Buy) | +161,139 | 161,139 | ||
| 2021-03-01 | ELDER WILLIAM ROBERT GC & Secretary | Grant or award · Stock Option (Right to Buy) | +87,684 | 87,684 | ||
| 2021-03-01 | ELDER WILLIAM ROBERT GC & Secretary | Grant or award · Stock Option (Right to Buy) | +62,522 | 62,522 | ||
| 2021-03-01 | GALLOWAY CHRISTOPHER D Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +27,180 | 27,180 | ||
| 2021-03-01 | GALLOWAY CHRISTOPHER D Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +81,537 | 81,537 | ||
| 2021-03-01 | Hornung William Karl Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +122,771 | 122,771 |
Page 8 of 17 · 321 trades